|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | G01N 33/50 | (2006.01) |
| G01N 33/94 | (2006.01) | ||
| A61P 29/00 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 43/00 | (2006.01) |
| (11) | Patento numeris | 3304085 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16799471.4 |
| Europos patento paraiškos padavimo data | 2016-05-04 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-04-11 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-06-23 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IL2016/050471 |
| Data | 2016-05-04 |
| (87) | Numeris | WO 2016/189525 |
| Data | 2016-12-01 |
| (30) | Numeris | Data | Šalis |
| 201562166716 P | 2015-05-27 | US |
| (72) |
BALLAN, Eyal , IL
|
| (73) |
Cannabics Pharmaceuticals Inc ,
No. 3 Bethesda Metro Center
Suite 700, Bethesda, Maryland 20814,
US
|
| (54) | SYSTEM AND METHOD FOR HIGH THROUGHPUT SCREENING OF CANCER CELLS |
| SYSTEM AND METHOD FOR HIGH THROUGHPUT SCREENING OF CANCER CELLS |